+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effect of norandrostenolone-decanoate on calcium tolerance curves of patients with primary osteoporosis. Data on the mode of action of anabolic compounds in osteoporosis



Effect of norandrostenolone-decanoate on calcium tolerance curves of patients with primary osteoporosis. Data on the mode of action of anabolic compounds in osteoporosis



Endokrinologie 58(3): 326-330




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 042920534

Download citation: RISBibTeXText

PMID: 5142365


Related references

The effect of Retabolil on the serum calcium loading curve in patients with osteoporosis. The mechanism of action of anabolic drugs in osteoporosis. Orvosi Hetilap 112(6): 325-326, 1971

Study on the renoprotective action of a new anabolic steroid: 19-norandrostenolone decanoate. Minerva Urologica 15: 6-10, 1963

Norandrostenolone decanoate-a new anabolic steroid with prolonged effect. Some clinical observations. Annales Medicinae Internae Fenniae 50: 177-184, 1961

Studies on osteoporosis VII. Effect of 17 beta-hydroxy-4-estren-3-one 17-decanoate on experimental osteoporosis. Steroids 40(2): 125-132, 1982

Treatment of postmenopausal osteoporosis is the anabolic steroid nandrolone decanoate a candidate. Bone & Mineral 6(1): 77-86, 1989

Double-blind placebo-controlled trial of treatment of osteoporosis with the anabolic nandrolone decanoate. Osteoporosis International 3 Suppl 1: 218-222, 1993

The evidence for efficacy of osteoporosis treatment in men with primary osteoporosis: a systematic review and meta-analysis of antiresorptive and anabolic treatment in men. Journal of Osteoporosis 2011: 259818, 2011

Contribution on osteoporosis therapy. Norandrostenolone phenylpropionate in senile osteoporosis with regard to ambulant therapy. Wiener Klinische Wochenschrift 73: 820-822, 1961

Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 4. Calcium nutrition and osteoporosis. Cmaj 155(7): 935-939, 1996

Effect of hydrochlorothiazide on calcium concentration in serum and urine of patients with primary osteoporosis. Polski Tygodnik Lekarski 29(33): 1441-1442, 1974

Time therapy with calcium and phosphate supplements restores phosphate and parathyroid hormone rhythms in patients with osteoporosis, with an anabolic effect on spinal bone mineral density. British Journal of Rheumatology 35(ABSTR SUPPL 1): 88, 1996

Timed therapy with calcium and phosphate supplements restores phosphate and parathyroid hormone rhythms in patients with osteoporosis, with an anabolic effect on spinal bone mineral density. Journal of Endocrinology 148(SUPPL ): P192, 1996

Norandrostenolone phenylpropionate and norandrostenolone decanoate in the treatment of metastasizing mammary carcinoma. Acta Endocrinologica. Supplementum: 132-142, 1961

Treatment of primary osteoporosis with fluoride and calcium. Clinical tolerance and fracture occurrence. JAMA 243(5): 446-449, 1980

Natural history of bone mineral content and cortical thickness in female patients with axial osteoporosis after treatment with nandrolone decanoate 1 alpha hydroxyvitamin d and intermittent calcium infusions. Calcified Tissue International 39(SUPPL): A19, 1986